NCT02002039View on ClinicalTrials.gov

Neuroprotective Role of Erythropoietin in Perinatal Asphyxia

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Perinatal Asphyxia
Interventions
DRUG

Erythropoietin

500 units /kg /day every other day for 5 doses

Trial Locations (1)

Unknown

Sheri-Kashmir Institute of Medical Sciences, Srinagar

All Listed Sponsors
lead

Sheri Kashmir Institute of Medical Sciences

OTHER

NCT02002039 - Neuroprotective Role of Erythropoietin in Perinatal Asphyxia | Biotech Hunter | Biotech Hunter